• 1
    Siegel, R., D. Naishadham, and A. Jemal. 2012. Cancer statistics, 2012. CA Cancer J. Clin. 62:1029.
  • 2
    Pour, P. M., R. H. Bell, and S. K. Batra. 2003. Neural invasion in the staging of pancreatic cancer. Pancreas 26:322325.
  • 3
    Bapat, A. A., G. Hostetter, D. D. Von Hoff, and H. Han. 2011. Perineural invasion and associated pain in pancreatic cancer. Nat. Rev. Cancer 11:695707.
  • 4
    Liebig, C., G. Ayala, J. A. Wilks, D. H. Berger, and D. Albo. 2009. Perineural invasion in cancer: a review of the literature. Cancer 115:33793391.
  • 5
    Ceyhan, G. O., C. W. Michalski, I. E. Demir, M. W. Muller, and H. Friess. 2008. Pancreatic pain. Best Pract. Res. Clin. Gastroenterol. 22:3144.
  • 6
    Chu, C. K., A. E. Mazo, M. Goodman, V. Egnatashvili, J. M. Sarmiento, C. A. Staley, et al. 2010. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann. Surg. Oncol. 17:502513.
  • 7
    Kumar, A., G. Negi, and S. S. Sharma. 2012. Suppression of NF-kappaB and NF-kappaB regulated oxidative stress and neuroinflammation by BAY 11–7082 (IkappaB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 94:11581165.
  • 8
    Li, J., and Q. Ma. 2008. Hyperglycemia promotes the perineural invasion in pancreatic cancer. Med. Hypotheses 71:386389.
  • 9
    Li, J., Q. Ma, H. Liu, K. Guo, F. Li, W. Li, et al. 2011. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS ONE 6:e17385.
  • 10
    Hassan, M. M., M. L. Bondy, R. A. Wolff, J. L. Abbruzzese, J. N. Vauthey, P. W. Pisters, et al. 2007. Risk factors for pancreatic cancer: case–control study. Am. J. Gastroenterol. 102:26962707.
    Direct Link:
  • 11
    Li, D., J. S. Morris, J. Liu, M. M. Hassan, R. S. Day, M. L. Bondy, et al. 2009. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:25532562.
  • 12
    Li, D., S. C. Yeung, M. M. Hassan, M. Konopleva, and J. L. Abbruzzese. 2009. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482488.
  • 13
    Chatterjee, D., M. H. Katz, A. Rashid, H. Wang, A. C. Iuga, G. R. Varadhachary, et al. 2012. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am. J. Surg. Pathol. 36:409417.
  • 14
    Sadeghi, N., J. L. Abbruzzese, S. C. Yeung, M. Hassan, and D. Li. 2012. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin. Cancer Res. 18:29052912.
  • 15
    Ceyhan, G. O., I. E. Demir, B. Altintas, U. Rauch, G. Thiel, M. W. Muller, et al. 2008. Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells. Biochem. Biophys. Res. Commun. 374:442447.
  • 16
    Gil, Z., O. Cavel, K. Kelly, P. Brader, A. Rein, S. P. Gao, et al. 2010. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J. Natl. Cancer Inst. 102:107118.
  • 17
    Miknyoczki, S. J., D. Lang, L. Huang, A. J. Klein-Szanto, C. A. Dionne, and B. A. Ruggeri. 1999. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int. J. Cancer 81:417427.
  • 18
    Ma, J., Y. Jiang, Y. Sun, and X. Zhao. 2008. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J. Gastroenterol. Hepatol. 23:18521859.
  • 19
    Marchesi, F., L. Piemonti, G. Fedele, A. Destro, M. Roncalli, L. Albarello, et al. 2008. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res. 68:90609069.
  • 20
    Ceyhan, G. O., K. H. Schafer, A. G. Kerscher, U. Rauch, I. E. Demir, M. Kadihasanoglu, et al. 2010. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann. Surg. 251:923931.
  • 21
    Bruckner, B. A., C. V. Ammini, M. P. Otal, M. K. Raizada, and P. W. Stacpoole. 1999. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 48:422431.
  • 22
    Vincent, A. M., B. C. Callaghan, A. L. Smith, and E. L. Feldman. 2011. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat. Rev. Neurol. 7:573583.
  • 23
    Bockman, D. E., M. Buchler, and H. G. Beger. 1994. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology 107:219230.
  • 24
    Marchesi, F., L. Piemonti, A. Mantovani, and P. Allavena. 2010. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 21:7782.
  • 25
    Vinik, A. I., R. E. Maser, B. D. Mitchell, and R. Freeman. 2003. Diabetic autonomic neuropathy. Diabetes Care 26:15531579.